Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2022-05-12
- Target Recruit Count
- 104
- Registration Number
- NCT03545035
- Locations
- 🇮🇹
I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy
🇮🇹Aou Di Modena - Sc Ematologia, Modena, Italy
🇮🇹Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2022-05-12
- Target Recruit Count
- 109
- Registration Number
- NCT03528941
- Locations
- 🇮🇹
AOU Arcispedale S.Anna - UOC Ematologia e fisiopatologia della coagulazione, Cona, Ferrara, Italy
🇮🇹AOU Maggiore della Carità di Novara - SCDU Ematologia, Novara, Italy
🇮🇹AOU Città della Salute e della Scienza, Ospedale S.Giovanni Battista Molinette - SC Ematologia, Torino, Italy
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
- Conditions
- Idiopathic Thrombocytopenic Purpura
- Interventions
- Other: Observation
- First Posted Date
- 2018-03-14
- Last Posted Date
- 2022-07-20
- Target Recruit Count
- 861
- Registration Number
- NCT03465020
- Locations
- 🇮🇹
Sc Ematologia E Centro Trapianti Midollo Osseo, Parma, SC, Italy
🇮🇹Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
🇮🇹Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy
Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2023-11-24
- Target Recruit Count
- 77
- Registration Number
- NCT03455517
- Locations
- 🇮🇹
Ao Di Perugia, Ospedale S. Maria Della Misericordia - Ematologia E Trapianto Midollo Osseo, Perugia, Italy
🇮🇹Fondazione Policlinico Universitario Agostino Gemelli Irccs - Roma - Area Ematologica, Roma, Italy
🇮🇹Università degli Studi di Roma "Sapienza", Roma, Italy
Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
- First Posted Date
- 2018-03-06
- Last Posted Date
- 2024-04-10
- Target Recruit Count
- 124
- Registration Number
- NCT03455504
- Locations
- 🇮🇹
Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
🇮🇹Spedali Civili - Azienda Ospedaliera U.O. Ematologia, Brescia, Italy
🇮🇹Asl Salerno, Presidio Ospedaliero Tortora Pagani - Ematologia, Pagani, Italy
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Other: Observation of CNS involvement
- First Posted Date
- 2018-01-25
- Last Posted Date
- 2022-10-26
- Target Recruit Count
- 21
- Registration Number
- NCT03410407
- Locations
- 🇮🇹
Asl Di Piacenza, Ospedale "Guglielmo Da Saliceto" - Ematologia E Centro Trapianti, Piacenza, Italy
🇮🇹Aou Maggiore Della Carita' Di Novara - Scdu Ematologia, Novara, Italy
🇮🇹Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
- Conditions
- Philadelphia Chromosome-Negative B-Cell PrecursorAcute Lymphoid Leukemia
- Interventions
- Drug: Chemotherapy + Blinatumomab
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2025-01-22
- Target Recruit Count
- 149
- Registration Number
- NCT03367299
- Locations
- 🇮🇹
UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro, Bari, Italy
🇮🇹Azienda Ospedaliera - Papa Giovanni XXIII, Bergamo, Italy
🇮🇹UOC di Ematologia - Istituto Tumori - Giovanni Paolo II, Bari, Italy
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2022-10-12
- Target Recruit Count
- 60
- Registration Number
- NCT03318770
- Locations
- 🇮🇹
Asst Papa Giovanni Xxiii - Ospedale Di Bergamo - Sc Ematologia, Bergamo, Italy
🇮🇹Aou Careggi - Firenze - Sod Ematologia, Firenze, Italy
🇮🇹Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Other: Quality of life questionnaires
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2022-06-29
- Target Recruit Count
- 520
- Registration Number
- NCT03190525
- Locations
- 🇮🇹
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI, Ancona, Italy
🇮🇹S. Orsola Malpighi, Bologna, Italy
🇮🇹Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy
Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy
- Conditions
- Acute Promyelocytic Leukemia
- Interventions
- Other: QoL questionnaires
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2021-02-08
- Target Recruit Count
- 161
- Registration Number
- NCT03096496
- Locations
- 🇮🇹
Spedali Civili - Brescia - Azienda Ospedaliera - U.O. Ematologia, Brescia, Italy
🇮🇹UOC Ematologia e Terapia Cellulare - Ospedale C. e G. Mazzoni di Ascoli Piceno, Ascoli Piceno, Italy
🇮🇹Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia - Padiglione Marcora 2do piano, Milano, Italy